The electrogenic sodium bicarbonate cotransporter NBCe1 (SLC4A4) expressed in astrocytes regulates intracellular and extracellular pH. Here, we introduce transforming growth factor beta (TGF-b) as a novel regulator of NBCe1 transcription and functional expression. Using hippocampal slices and primary hippocampal and cortical astrocyte cultures, we investigated regulation of NBCe1 and eluci- 
| I N T R O D U C T I O N
The key physiological roles for central nervous system (CNS) astrocytes include contribution to CNS development, homeostatic function, metabolic support, as well as modulation of neuronal signaling and synaptic transmission. Moreover, astroglia is meanwhile considered as a possible target for medical intervention. Under pathophysiological conditions, astrocytes undergo key changes and morphological alterations, and changes on the expression of ion channels, transporters and receptors, have been established as astrocytic responses to insults.
The electrogenic Na 1 /HCO 2 3 cotransporter (NBCe1) (Majumdar & Bevensee, 2010; Rickmann, Orlowski, Heupel, & Roussa, 2007; Theparambil, Ruminot, Schneider, Shull, & Deitmer, 2014 ) is crucial for regulating astrocytic intracellular pH and additionally for maintaining ionic homeostasis between intracellular and extracellular space. In turn, ionic composition of the extracellular space affects several cell functions in neurons and astrocytes. In particular, changes on extracellular or intracellular pH maybe associated with several pathophysiological conditions and considerably influence brain function. Glial NBCe1 operates with a stoichiometry of 1Na 1 in both directions across the glial cell membrane (Brookes & Turner, 1994; Brune, Fetzer, Backus, & Deitmer, 1994; Deitmer, 1991) . Whereas neuronal firing leads to depolarization-induced alkalinisation in astrocytes via activation of NBCe1, NBCe1 reverses during intracellular alkali load, thereby acting as an acid loader . NBCe1 plays also a crucial role in neuron-glial metabolic coupling (Ruminot et al., 2011; Theparambil, Weber, Schmälzle, Ruminot, & Deitmer, 2016) and might also represent a molecular component of neuron-astrocyte communication (Salameh, Hubner, & Boron, 2017) . Changes in expression and function of NBCe1 have been observed in different in vitro (Yao et al., 2016) and in vivo models (Jung, Choi, & Kwon, 2007; Sohn et al., 2011 ) of ischemia and in seizures (Kang et al., 2002) . We have previously shown that the K 1 channel blocker 4-aminopyridine (4AP) regulates NBCe1 transcript, protein, and functional expression in primary astrocyte cultures via c-jun N-terminal kinase (JNK), and proto-oncogene tyrosineprotein kinase Src signaling in a depolarization-independent manner (Schr€ odl-Häußel, Theparambil, Deitmer, & Roussa, 2015) .
The TGF-b superfamily of cytokines consists of more than 40 members, including TGF-bs, activins, inhibins, Nodal, bone morphogenetic proteins (BMPs), and growth differentiation factors (GDFs) (reviewed in Derynck & Miyazono, 2008) . into the nucleus, where transcription of target genes is activated (Derynck & Miyazono, 2008; Miyazawa, Shinozaki, Hara, Furuya, & Miyazono, 2002; Moustakas & Heldin, 2009 , reviewed in Akhurst & Hata, 2012 . However, TGF-b may also signal through other signaling pathways, such as ERK, p38, JNK, and MAPK pathways (Yang et al., 2003) that may act independently or in co-operation with the canonical pathway.
The role of TGF-b1 in the context of epilepsy has been studied in several in vitro and in vivo approaches (reviewed in Heinemann, Kaufer, & Friedman, 2012) . According to the current notion, disruption of the blood-brain-barrier (BBB) causes extravasation of albumin in the extracellular space which in turn interacts with astrocytic TGF-b receptors and activates TGF-b signaling cascades, resulting in secretion of TGF-b1 and increased hyperexcitability. TGF-b-dependent activation of astrocytes is accompanied by downregulation of K 1 inwardrectifying channels (Perillan, Chen, Potts, & Simard, 2002) , gap junctional proteins, and the glial excitatory amino acid transporters (EAAT1 and EAAT2), together with altered trafficking and surface expression of aquaporin 4 (AQP4). In epithelial cells, TGF-b1 has been shown to regulate trafficking and expression of transporters that are functionally coupled to NBCe1, among them CFTR (Roux et al., 2010; Yi, PierucciAlves, & Schultz, 2013 three isoforms, was obtained from R&D Systems. Activity of this antibody was determined using the mink lung epithelial cell system (MLEC) (Abe et al.,1994; Krieglstein et al., 2000) . 4-aminopyridine (4AP), Bicuculline methiodide, SP600125, and SB431542 were purchased from Tocris Bioscience (Bristol, UK). SIS3 was purchased from Millipore, and Leptomycin B from Sigma.
| Animals
All protocols were carried out in accordance with German ethical guidelines for laboratory animals and approved by the Institutional Animal Care and Use Committee of the University of Freiburg (authorizations: X-14/16H and X-15/06H). Adult C57BL/6N mice of either sex were maintained on a 12-hr dark/light cycle with food and water ad libitum. Mice were sacrificed by cervical dislocation, and all efforts were made to minimize suffering. Slc4a4 and Tgf-b2 deficient mice have been described earlier (Gawenis et al., 2007; Sanford et al., 1997) .
| Acute hippocampal slices
Acute hippocampal slices were generated from 4-to 6-week old mice (Lein, Barnhart, & Pessah, 2011 For primary culture of mixed glia, mouse pups aged P2/P3 were used, according to McCarthy & de Vellis, 1980 , as previously described (Schr€ odl-Häußel et al., 2015 . For obtaining cultures from Tgf-b2 deficient mice, embryos at embryonic day 18 (E18) were used. Experiments were carried out after 18-23 days in vitro, 12-18 hr before treatment, serum was deprived from the culture medium. Treatment conditions were 4AP
(100 mM) for 20 min, human recombinant TGF-b (2 ng/mL) for 60 min, and preincubation with anti-TGF-b 1,2,3 (10 mg/mL), SP600125, a JNK inhibitor (10 mM), SIS3, a pSmad3 blocker (3 mM) and SB431542, an inhibitor of Alk4, Alk5, and Alk7 (10 mM) for 30 min.
| Immunocytochemistry
Immunofluorescence of cultures has been performed as described (Brandes et al., 2007 
| Immunoblotting
Protein isolation from hippocampal slices or primary astrocytes, electrophoresis, and blotting procedures were performed as described (Schr€ odlHäußel et al., 2015) . Protein concentration was determined by Thermo Scientific NanoDrop 2000 spectrophotometer. Primary antibodies were diluted: NBCe1 1:10,000, GAPDH 1:10,000, pSmad2/pSmad3 1:1,000, Smad2/Smad3 1:1,000, Na 1 /K 1 ATPase 1:10,000, TGF-b 1:500. Blots were developed in enhanced chemiluminescence reagents, and signals were visualized on X-ray films. Films were scanned and the signal ratio protein of interest:housekeeping gene, was quantified densitometrically.
Differences in signal ratio were tested for significance using two tailed unpaired Student's t-test. For multiple comparisons one way ANOVA and Bonferroni post hoc test has been used. Results with levels of *p < .05, **p < .01, and ***p < .001 were considered significant.
| Cell surface biotinylation
Primary cortical astrocytes were subjected to control or experimental conditions and then kept on ice. Isolation of cell surface proteins was performed using the Pierce® cell surface protein isolation kit following the manufacturer's instructions. Proteins were then processed for immunoblotting with antibodies against NBCe1, Na by using the nigericin-based (4 mM) calibration technique (Theparambil et al., 2014) . Cells were perfused with calibration solution (in mM), containing, KCl 145, NaH 2 PO 4 0.4, Na 2 HPO 4 1.6, Glucose 5, MgCl 2 6H 2 O 1, Ca-DiGluconat H 2 O 1.3, adjusted at pH 6.5, 7.0, 7.5, and 8.0.
| MLEC assay
Primary cortical astrocytes were treated with or without 4AP for 20 min. Conditioned medium was collected for the mink lung epithelial cell (MLEC) assay. The principle of the assay is that the MLECs, containing a luciferase reporter under the control of a TGF-b-responsive truncated plasminogen activator inhibitor (PAI)-promoter, are able to generate luciferase in a TGF-bs dose-dependent manner. The MLECs only respond to the activated TGF-bs. To detect the latent part of TGF-bs, the conditioned medium has to be acidified first to convert latent TGFbs into activated ones. To evaluate the levels of activated TGF-bs in extracellular environment after 4AP treatment, the MLEC assay was performed as described by Abe et al. (1994) . MLECs were placed into 96-well plates at the density of 2 3 10 4 cells per well and treated with collected conditioned medium either with or without acidification with 1 M HCL and pH adjustment with 1 M NaOH (to activate latent TGFbs) for 18 hr. Cells were washed with PBS and total proteins were extracted using lysis buffer (Promega). The luciferase activity was analysed in duplicates using a luminometer (GloMax 96 Microplate Luminometer, Promega).
| Chromatin immunoprecipitation assay
Chromatin immunoprecipation (ChIP) assays and PCR were performed on control and TGF-b treated cortical astrocytes using EZ ChIP kit (Millipore), following the manufacturer's instructions. Briefly, DNA was crosslinked to protein with 1% paraformaldehyde. Cell lysates were obtained by scraping followed by sonication (Diagenode, Bioruptor Sonication Device) to shear cellular DNA. Overnight immunoprecipitations were performed with Histone 3 (H3), IgG, and an anti-Smad4
antibody. On the next day the crosslinks were reversed, and bound DNA was purified. Subsequently, PCR was performed using primers specific for Smad4 promoter sequences in mouse NBCe1. Primer sequences (with their starting positions in the promoter sequence) are:
Smad4 forward: 5 0 -AGCCACCAATGACACTCCTG-3 0 , Smad4 reverse:
The NBCe1 promoter sequence was retrieved using EnsEMBL, and conserved Smad4 binding sequence was identified by sequence alignment using ClustalW (EMBL-EBI).
| R E S U LTS
Previous data have shown that treatment of acute hippocampal slices fold, respectively, n 5 3, not significant using the Student's t-test).
However, following treatment for 30 min, NBCe1 gene expression was significantly upregulated (2.14 6 0.33 fold, n 5 3, *p < .05, using the Student's t-test), compared to controls. After 60 min TGF-b treatment
NBCe1 expression returned to baseline levels (1.15 6 0.11 fold, n 5 3).
| TGF-b is required for 4AP-dependent NBCe1 regulation of transcript and protein
Based on these data, we next investigated TGF-b requirement for 4AP-dependent NBCe1 upregulation in cortical ( Figure 1d ) and hippocampal astrocytes (Figure 1e ). Cultures were treated for 20 min either with 100 mM 4AP alone, or in the presence of SB431542 (10 mM) an Alk4, Alk5, and Alk7 inhibitor (Inman, 2002) , and therefore inhibitor of respectively, n 5 6, **p < .01 and *p < .05, using the Students t-test), confirming previous observations. TGF-b application significantly upregulated NBCe1 protein as well (1.31 6 0.13 fold and 1.23 6 .07
fold, for cortical and hippocampal astrocytes, respectively, n 5 6, **p < .01, using the Student's t-test), whereas SB431542 abolished the 4AP-dependent upregulation of NBCe1 protein (0.87 6 0.10 fold and 0.92 6 .04 fold, n 5 6, ## p < .01, using one way ANOVA and Bonferroni post hoc test). SB431542 under control conditions had no effect on NBCe1 protein as compared to untreated cultures (1.18 6 0.12 and 0.90 6 .00 fold, n 5 3). To test whether TGF-b-dependent upregulation of NBCe1 was accompanied by upregulation of NBCe1 surface expression as well, biotinylation of surface proteins was performed, followed by immunoblotting (Figure 1f) . Treatment of the cultures with either TGF-b or 4AP significantly upregulated NBCe1 surface expression (1.47 6 0.14 fold and 2.00 6 0.45 fold for TGF-b (n 5 3) and 4AP, respectively, *p < .05, using the Student's t-test), compared to the controls and SB431542 abolished the 4AP-dependent upregulation of NBCe1 surface protein (1.02 6 .07 fold, # p < .05).
These data have been confirmed by double immunofluorescence for NBCe1 and the astrocytic marker GFAP in cortical and hippocampal astrocytes and subsequent confocal microscopy ( Figure 1g ). NBCe1 immunoreactivity in control astrocytes was moderate and 3.24 nM/min, 246.26 6 4.31 nM/min and 140.6 6 10.7 nM). In contrast, application of SB431542 in control astrocytes had no effect on all parameters (31.07 6 1.81 nM/min, 228.20 6 1.36 nM/min, and 96.47 6 8.87), compared to the untreated controls (Figure 2b -e).
| Activation of TGF-b signaling regulates NBCe1 activity
The data presented in Figure 1c -e implicate regulation of NBCe1 transcript and protein following activation of TGF-b signaling. To test whether activation of TGF-b signaling specifically regulates NBCe1 activity in cortical astrocytes, we treated wild type (WT) and Slc4a4-deficient (NBCe1-KO) astrocytes with 2 ng/mL exogenous TGF-b and subsequently, NBCe1 activity was determined (Figure 2f,g ). ] from 7.4 and 26 mM to 7.1 and 13 mM, respectively, to challenge outwardly directed NBCe1 activity, before and after incubation with 4-AP (100 mM, 20 min), in control, and in the presence of the TGF-b receptor II inhibitor SB431542 (10 mM) (b-e). Bar plots of the rate of acidification (c), the rate of alkalinisation (d), and the amplitude (e) as measured upon changing external pH and [HCO ] from 7.4 and 26 mM to 7.1 and 13 mM, respectively, to challenge outwardly directed NBCe1 activity, before and after application of TGF-b (2 ng/mL, 60 min), in control, and in the presence of the Smad3 inhibitor SIS3 (3 mM) or the JNK inhibitor SP600125 (10 mM). Bar plots of the rate of acidification (b), the rate of alkalinisation (c), and the amplitude (d) as measured by changing external pH and [HCO 2 3 ] to 7.1 and 13 mM, respectively, and back to pH 7.4 and 26 mM [HCO 2 3 ], before and after incubation with TGF-b in controls, and in the presence of SIS3 or SP600125. **p < .01 and ***p < .001, for the significant increase, compared to the untreated controls, using the Student's t-test and # p < .05, and ### p < .001 for the significant decrease, compared to TGF-b, using one way ] i ) in cultured wild type (WT) and Tgf-b2-deficient (TGF-b2-KO) mouse cortical astrocytes during reduction of external pH and [HCO 2 3 ] from 7.4 and 26 mM to 7.1 and 13 mM, respectively, to challenge outwardly directed NBCe1 activity, before and after application of 4AP. Bar plots of the rate of acidification (b), the rate of alkalinisation (c), and the amplitude (d) as measured by changing external pH and [HCO 2 3 ] to 7.1 and 13 mM, respectively, and back to pH 7.4 and 26 mM [HCO 2 3 ], before and after incubation with 4AP in WT and TGF-b2-KO astrocytes (***p < .001, for significant increase, compared to the untreated (Ctr) WT astrocytes, ### p < .001 for significant increase, compared to untreated TGF-b2-KO astrocytes, using the Student's t-test, n 5 3). (e) Quantification of baseline pH i in untreated (Ctr) cortical astrocytes derived from either WT or Tgf-b2 deficient mice (not significant, using Student's t-test, n 5 3). (f) Immunoblotting for endogenous TGF-b1 protein in control and 4AP-treated cortical astrocytes (not significant after densitometric analysis of the signal ratio TGF-b1: GAPDH and Student's t-test, n 5 6). Protein of 50 mg was loaded per lane. (g) The amount of active and latent TGF-b in the extracellular environment was quantified with the MLEC/PAIluciferase assay. Data are given as relative amounts of TGF-b in the supernatant following 4AP treatment, as compared to the untreated controls (*p < .05 and **p < .01, using the Student's t-test, n 5 3)
no effect on the rate of acidification (33.47 6 1.90 nM/min), but significantly decreased the rate of alkalinisation (-38.50 6 1.43 nM/ min), and the amplitude (109.3 6 4.93 nM), compared to TGF-b treatment.
We have previously shown that the isoform 2 of TGF-b (TGF-b2) is able to increase trafficking and functional expression of K 1 /Cl -cotransporter 2 in mouse hippocampal neurons (Roussa et al., 2016) . We therefore asked whether TGF-b2 is the isoform required for 4AP-dependent .03 fold, n 5 3 *p < .05) and significantly decreased latent TGF-b (0.50 6 .08 fold, **p < .01, n 5 3, using the Student's t-test) present in the medium.
| TGF-b directly activates NBCe1 transcription via Smad4
To provide conclusive evidence that TGF-b can directly upregulate NBCe1 via the canonical pathway, we performed a search for conserved Smad binding sequence in the promoter region of NBCe1 (Figure 6a) . Indeed, the NBCe1 promoter on chromosome 5: 88886260- 
| DISCUSSION
Intracellular pH (pH i ) regulation is a homeostatic process fundamental for cellular function and survival. In astrocytes, regulation of pH i is of particular importance because astrocytes control the ionic environment of the neuropil, thereby contributing to modulation of neuronal signaling and synaptic transmission (Deitmer & Rose, 2010; Haydon & Carmignoto, 2006) . Hence, one of the fundamental questions is to identify regulatory signals that orchestrate expression, trafficking, and activity of acid-base transporters, among them of NBCe1.
In the present work, we have hypothetised that TGF-b regulates
NBCe1. This hypothesis was based on following observations: First, the role of TGF-bs in epileptogenesis and a TGF-b-dependent activation of astrocytes with subsequent changes in expression and trafficking of channels and transporters is well established (Heinemann et al., 2012) . Second, in an in vitro model of epilepsy (4AP treatment), NBCe1 expression was upregulated in both hippocampal slices and astrocytes (Schr€ odl-Häußel et al., 2015) . And third, in other cellular paradigms, TGF-b regulates transporters that are functionally coupled to NBCe1 (Roux et al., 2010; Yi et al., 2013) .
We show that blocking of TGF-bs in acute hippocampal slices prevented 4AP-and bicuculline-dependent NBCe1 upregulation ( Figure   1a ,b). NBCe1 is highly expressed in astrocytes and responsible for the bulk of bicarbonate movement across the astrocytic membrane (Deitmer & Rose, 1996 . However, neurons express also NBCe1 (Rickmann et al., 2007; Svichar, Esquenazi, Chen, & Chesler, 2011) , and NBCe1 has even been considered to act by an unknown mechanism as communication molecule between neurons and astrocytes (Salameh et al., 2017) . Moreover, TGF-b is activity-dependent released by neurons (Lacmann, Hess, Gohla, Roussa, & Krieglstein, 2007) , highlighting the complexity of the network. Although we cannot exclude that the effects observed in acute slices may partly result from neuron/glia interactions, we have previously shown that 4AP has its own effect on astrocytes which is totally independent of neurons (Schr€ odl-Häußel et al., 2015) . We have therefore focused on astrocytes to analyse the impact of TGF-b on NBCe1.
NBCe1 transcript, protein, and activity can be regulated by Src/ ERK signaling (Namkoong et al., 2015; Schr€ odl-Häußel et al., 2015) , and surface expression and activity by phosphorylation (Hong et al., 2013; Thornell & Bevensee, 2015) , JNK signaling (Schr€ odl-Häußel et al., 2015) , and intracellular bicarbonate concentration . However, the question whether intrinsic stimuli, by means of signaling molecules and growth factors might initiate changes in (2) inhibition of TGF-b signaling significantly decreased 4AP-dependent upregulation of NBCe1 transport activity (Figure 2b-d) . This effect is specific for 4AP, since inhibition of TGF-b signaling in control astrocytes had no effect on NBCe1 (Figure 2b-d) . We have used SB431542
to block TGF-b signaling (Inman, 2002) . Because this inhibitor inhibits Alk4, 5, and 7, we have performed initial experiments with a-TGF- Since astrocytes express TGF-b1 and TGF-b2 (Vivien et al., 1998), we asked which isoform is responsible for the regulation of NBCe1. The phenotypes resulting from the knockout of the mammalian TGF-b isoforms are very distinct (reviewed in D€ unker & Krieglstein, 2000) . We have recently shown that TGF-b2 regulates functional expression of the neuronal K 1 /Cl -cotransporter 2 (KCC2) (Roussa et al., 2016) , a molecular component increasingly appreciated in the context of epilepsy (Kelley et al., 2016; Kourdougli, Varpula, Chazal, & Rivera, 2015) . We have hypothesized that TGF-b2 is the isoform required for 4AP-dependent NBCe1 regulation. In both WT and Tgf-b2-/-astrocytes NBCe1 transport activity was significantly increased (Figure 5b-d) , while baseline pH i was comparable between WT and TGF-b2-KO (Figure 5e ). These data imply that other molecular mechanisms are activated and upregulate NBCe1 activity in order to compensate for TGF-b2 loss and to maintain pH i homeostasis. These data suggest that TGF-b2 is necessary but not 
